You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 211 No. 8, February 23, 1970 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Report to the Secretary of HEW From the Medical Advisory Group on Cyclamates

Roger O. Egeberg, MD; Jesse L. Steinfeld, MD; Ivan Frantz, MD; George C. Griffith, MD; Harvey Knowles, Jr., MD; Edward Rosenow, MD; Henry Sebrell, MD; Theodore Van Itallie, MD

JAMA. 1970;211(8):1358-1361.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The Medical Advisory Group on Cyclamates appointed by Secretary Finch met on Nov 17 and 18, 1969, with representatives of the Food and Drug Administration and the National Institutes of Health to review the currently available data on the possible harmful effects of these nonnutritive sweeteners in relation to their potential benefits. The group considered the data on carcinogenic, mutagenic, teratogenic, enzymatic, osmotic, and growth effects of cyclamates and on their possible adverse influence in interaction with other drugs.

After carefully reviewing the evidence currently available, the Medical Advisory Group on Cyclamates unanimously supported the secretary's prohibition of the inclusion of cyclamates in beverages for general use, and in the future processing of general purpose foods and vegetables. It recognized, however, that in the medical management of individuals with diabetes (and particularly in the case of juvenile diabetes) or patients in whom weight reduction and control are essential for health, . . . [Full Text PDF of this Article]


Author Affiliations

From the Department of Health, Education, and Welfare (Dr. Egeberg [Chairman]), and Office of the Surgeon General, Public Health Service (Dr. Steinfeld), Washington, DC; University of Minnesota. Minneapolis (Dr. Frantz); School of Medicine, University of Southern California, Los Angeles (Dr. Griffith); University of Cincinnati. Cincinnati, Ohio (Dr. Knowles); American College of Physicians, Philadelphia (Dr. Rosenow); and Columbia University (Dr. Sebrell), and St. Lukes Hospital (Dr. Van Itallie), New York.


Footnotes

Reprint requests to Surgeon General of the Public Health Service, Department of Health, Education, and Welfare, Washington, DC 20201 (Dr. Steinfeld).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.